We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. 2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer.
U.S. FDA Approval of Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy; Commercial Launch Underway Completion of R&D Pipeline...
2seventy bio, Inc. (Nasdaq: TSVT) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can...
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial, with a 51% reduction in risk of disease progression or death and a well-established safety...
- Company Now Exclusively Focused on Development and Commercialization of Abecma - 2seventy bio, Inc. (Nasdaq: TSVT), announced today the completion of the asset purchase agreement (“APA”) by...
2seventy bio, Inc. (Nasdaq: TSVT), announced today that Eli Casdin, Chief Investment Officer, and Founder of Casdin Capital, and Charles Newton, Chief Financial Officer, Lyell Immunopharma, have...
The supplemental Biologics License Application for Abecma in this indication remains under review with the FDA; Abecma has been approved in Japan and Switzerland and received a positive CHMP...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.33 | 7.38255033557 | 4.47 | 5.03 | 4.24 | 360936 | 4.6996041 | CS |
| 4 | 0.19 | 4.12147505423 | 4.61 | 5.1299 | 3.44 | 633149 | 4.5327726 | CS |
| 12 | -0.32 | -6.25 | 5.12 | 6 | 3.44 | 1066119 | 4.82849449 | CS |
| 26 | 2.59 | 117.194570136 | 2.21 | 6.4 | 1.535 | 1489234 | 4.01329591 | CS |
| 52 | -6.26 | -56.6003616637 | 11.06 | 12.69 | 1.535 | 1397469 | 4.75056655 | CS |
| 156 | -21.33 | -81.6303099885 | 26.13 | 44.34 | 1.535 | 888201 | 8.62143649 | CS |
| 260 | -21.33 | -81.6303099885 | 26.13 | 44.34 | 1.535 | 888201 | 8.62143649 | CS |
Monksdream
3 weeks ago
Invest-in-America
2 months ago
Monksdream
2 months ago
molee
4 months ago
Monksdream
5 months ago
johnhancoque
6 months ago
molee
7 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
